Work

P03.03 MERMAID-1: A Phase III Study of Adjuvant Durvalumab plus Chemotherapy in Resected NSCLC Patients with MRD+ Post-Surgery

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.376

Authors: S. Peters, D. Spigel, M. Ahn, M. Tsuboi, J. Chaft, D. Harpole, G. Goss, F. Barlesi, C. Abbosh, L. Poole, R. May, P.A. Dennis, C. Swanton

Institutions: Centre Hospitalier Universitaire Vaudois, Tennessee Oncology, Sungkyunkwan University, National Cancer Center Hospital East, Memorial Sloan Kettering Cancer Center, Duke Medical Center, Ottawa Hospital, The Francis Crick Institute, AstraZeneca (United States)

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3137318920

Cites:

Cited by: 59

Related to: 10